Highly rated in
Highly rated in
Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

Check Dr. Michael R. Debaun's experience treating your condition:
About Dr. Michael R. Debaun

Michael Debaun is a Pediatric Hematologist Oncology specialist and a Hematologist in Nashville, Tennessee. Debaun has been practicing medicine for over 35 years and is highly rated in 8 conditions, according to our data. His top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, Hemolytic Anemia, and Bone Marrow Transplant. He is licensed to treat patients in Tennessee. Debaun is currently accepting new patients.

His clinical research consists of co-authoring 241 peer reviewed articles and participating in 12 clinical trials in the past 15 years.


MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Michael R. Debaun it is best to call his office and ask if your insurance is accepted.

Dr. Michael R. Debaun accepts the following insurance:

  •  Blue Cross Blue Shield
  •  Ambetter
  •  Cigna
  •  Alliant Health

Call to see if your plan is accepted.
2200 Childrens Way, Nashville, TN 37232
Background & Education
Graduate Institution
Stanford University School Of Medicine, 1987
Pediatric Hematology Oncology
Internal Medicine in TN
Hospital Affiliations
Vanderbilt University Medical Center
Languages Spoken
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

12 Clinical Trials

Management of Severe Acute Malnutrition in Children With Sickle Cell Disease Greater Than 5 Years of Age Living in Northern Nigeria
Primary Prevention of Stroke in Children With Sickle Cell Disease in Sub-Saharan Africa II
Macrolide Therapy to Improve Forced Expiratory Volume in 1 Second in Adults With Sickle Cell Disease: a Feasibility Trial
Phase 2 Study of Montelukast for the Treatment of Sickle Cell Anemia (Also Known as the Montelukast Trial in Sickle Cell Anemia)
Stroke Prevention in Young Adults With Sickle Cell Anemia
Hydroxyurea for Stroke Prevention in Children With Sickle Cell Disease in Sub-Saharan Africa
Stroke Registry for Children and Young Adults With Sickle Cell Disease in Nigeria - The Afolabi Stroke Registry
Inhaled Corticosteroid Use to Prevent Acute Chest Syndrome Recurrence in Children Between 1 and 4 With Sickle Cell Disease: a Feasibility Trial
Silent Cerebral Infarct Transfusion Multi-Center Clinical Trial
View 9 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
Learn about our expert tiers
Learn more
Similar Doctors